ATE543492T1 - Behandlung von lungenkrebs - Google Patents
Behandlung von lungenkrebsInfo
- Publication number
- ATE543492T1 ATE543492T1 AT07849582T AT07849582T ATE543492T1 AT E543492 T1 ATE543492 T1 AT E543492T1 AT 07849582 T AT07849582 T AT 07849582T AT 07849582 T AT07849582 T AT 07849582T AT E543492 T1 ATE543492 T1 AT E543492T1
- Authority
- AT
- Austria
- Prior art keywords
- lung cancer
- treatment
- fts
- disclosed
- analogs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87591506P | 2006-12-19 | 2006-12-19 | |
| PCT/IL2007/001556 WO2008075342A1 (en) | 2006-12-19 | 2007-12-17 | Treatment of lung cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE543492T1 true ATE543492T1 (de) | 2012-02-15 |
Family
ID=39203260
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07849582T ATE543492T1 (de) | 2006-12-19 | 2007-12-17 | Behandlung von lungenkrebs |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US8232253B2 (de) |
| EP (1) | EP2094260B1 (de) |
| AT (1) | ATE543492T1 (de) |
| CA (1) | CA2672839C (de) |
| MX (1) | MX2009006574A (de) |
| WO (1) | WO2008075342A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007064448A2 (en) | 2005-11-28 | 2007-06-07 | Ramot At Tel Aviv University, Ltd. | Cancer treatment using fts and 2-deoxyglucose |
| EP2094260B1 (de) * | 2006-12-19 | 2012-02-01 | Ramot at Tel-Aviv University Ltd. | Behandlung von lungenkrebs |
| WO2011056542A1 (en) * | 2009-10-26 | 2011-05-12 | Ramot At Tel-Aviv University Ltd. | Cancer therapy with combinations of fts with hdac inhibitors |
| WO2012129281A2 (en) * | 2011-03-22 | 2012-09-27 | The General Hospital Corporation | Detection of targets using magnetic resonance |
| US9738614B2 (en) | 2011-10-07 | 2017-08-22 | Pisces Therapeutics, Llc | Malignant and non-malignant disease treatment with Ras antagonists |
| ES2642843T3 (es) | 2011-10-07 | 2017-11-20 | Pisces Therapeutics Llc | Tratamiento de enfermedad maligna y no maligna con antagonistas de Ras |
| US9474730B2 (en) * | 2012-04-30 | 2016-10-25 | Board Of Regents Of The University Of Texas System | Methods and compositions for use with K-ras mediated disorders |
| CN104292139B (zh) * | 2014-08-25 | 2016-04-13 | 南通大学 | 法尼基硫醚取代的查尔酮衍生物及制备方法和用途 |
| CN104292140B (zh) * | 2014-08-25 | 2016-06-29 | 南通大学 | 含有查尔酮骨架的法尼基硫代水杨酸类似物及制备方法和用途 |
| BR112017019918B1 (pt) | 2015-03-19 | 2023-11-07 | Daiichi Sankyo Company, Limited | Preparação sólida farmacêutica, e, método para produzir uma preparação sólida farmacêutica para estabilizar uma preparação sólida farmacêutica |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL107587A (en) * | 1993-11-12 | 1998-08-16 | Univ Ramot | Farnesyl geranyl or geranyl-geranyl derivatives pharmaceutical compositions containing them and methods for their preparation |
| US20020115696A1 (en) * | 1999-06-18 | 2002-08-22 | Yoel Kloog | Treatment of post-angioplasty restenosis and atherosclerosis with ras antagonists |
| US20040072258A1 (en) * | 2000-10-04 | 2004-04-15 | Yoel Kloog | Isoprenoid-dependent ras anchorage (idra) proteins |
| EP2301528B1 (de) | 2004-08-18 | 2013-04-03 | Kadmon Corporation, LLC | Verwendung von FTS zur Behandlung von malignen Erkrankungen |
| WO2007064448A2 (en) | 2005-11-28 | 2007-06-07 | Ramot At Tel Aviv University, Ltd. | Cancer treatment using fts and 2-deoxyglucose |
| EP2094260B1 (de) * | 2006-12-19 | 2012-02-01 | Ramot at Tel-Aviv University Ltd. | Behandlung von lungenkrebs |
-
2007
- 2007-12-17 EP EP07849582A patent/EP2094260B1/de not_active Not-in-force
- 2007-12-17 WO PCT/IL2007/001556 patent/WO2008075342A1/en not_active Ceased
- 2007-12-17 AT AT07849582T patent/ATE543492T1/de active
- 2007-12-17 MX MX2009006574A patent/MX2009006574A/es active IP Right Grant
- 2007-12-17 US US12/519,578 patent/US8232253B2/en not_active Expired - Fee Related
- 2007-12-17 CA CA2672839A patent/CA2672839C/en not_active Expired - Fee Related
-
2012
- 2012-07-27 US US13/559,737 patent/US20120294957A1/en not_active Abandoned
-
2013
- 2013-11-27 US US14/091,861 patent/US20140088123A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008075342A1 (en) | 2008-06-26 |
| US20100136138A1 (en) | 2010-06-03 |
| US20140088123A1 (en) | 2014-03-27 |
| US20120294957A1 (en) | 2012-11-22 |
| CA2672839A1 (en) | 2008-06-26 |
| EP2094260B1 (de) | 2012-02-01 |
| EP2094260A1 (de) | 2009-09-02 |
| CA2672839C (en) | 2012-07-03 |
| US8232253B2 (en) | 2012-07-31 |
| MX2009006574A (es) | 2009-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE543492T1 (de) | Behandlung von lungenkrebs | |
| EA201490254A1 (ru) | Комбинированное лечение гепатита с | |
| EA200970932A1 (ru) | Способы лечения с применением пиридопиримидиноновых ингибиторов pi3k альфа | |
| EA200970935A1 (ru) | Способы лечения с применением хинаксолиновых ингибиторов pi3k-альфа | |
| EA201100971A1 (ru) | Производные пиримидининдола для лечения злокачественного новообразования | |
| EA201000914A1 (ru) | Новые терапевтические подходы в лечении смт и связанных с ней расстройств | |
| UA114726C2 (uk) | 1,4-дизаміщені аналоги піридазину та способи лікування пов'язаних з дефіцитом smn станів | |
| AR072442A1 (es) | Metodo para la terapia del cancer, uso, kit | |
| BR112015029491A2 (pt) | derivados de imidazopirrolidinona e seu uso no tratamento de doença | |
| EA201592250A1 (ru) | Пиразолопирролидиновые производные и их применение в лечение заболеваний | |
| ECSP099436A (es) | Acilaminopirazoles como inhibidores de fgfr | |
| RU2013148721A (ru) | Комбинации соединений, ингибирующих акт и вемурафениба и способы их применения | |
| EA200971107A1 (ru) | Катехоламиновые производные, полезные для лечения болезни паркинсона | |
| EA201391286A1 (ru) | Лечение солидных опухолей | |
| BRPI0908635B8 (pt) | composto e/ou um sal farmaceuticamente aceitável do mesmo e composição farmacêutica | |
| EA201071038A1 (ru) | Производные 1-бензил-3-гидроксиметилиндазола и их применение для лечения заболеваний, основанных на экспрессии mcp-1, cx3cr1 и p40 | |
| AR057295A1 (es) | Combinaciones y procedimientos para usar un compuestos de indolinona | |
| IL192100A0 (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain | |
| TNSN07419A1 (en) | Methods for treating drug resistant cancer | |
| MX2018012165A (es) | Metodos de tratamiento de canceres pediatricos. | |
| EA200970345A1 (ru) | Лечение гипербилирубинемии новорожденных с использованием низких дозировок станнсопорфина | |
| MX2009005798A (es) | Recuperacion de apoplejia. | |
| EA201071352A1 (ru) | Трициклические азотсодержащие соединения и их применение в качестве бактерицидных средств | |
| EA201490199A1 (ru) | Терапевтические способы | |
| EA200700407A1 (ru) | Производные хиназолина и их использования при лечении тромбоцитемии |